By Eric L. Foxman, R.PH., AAHP Secretary Of all the Warning Letters issued by the FDA, very few go to homeopathic manufacturers or marketers. That’s good. On the other hand, the few that are addressed to members of our industry reveal a wide divide between what is required by 21 readm more…

Read More

By Mark Land, AAHP President As remarkable as the limitations of this pandemic year have been, I am also astonished by the resiliency of people, technology, and organizations including AAHP. Despite challenges in travel, communications, and interactions brought on by the pandemic AAHP will remember 2020 as one of its readm more…

Read More